Clinical Study

Complement C3c as a Biomarker in Heart Failure

Table 1

Baseline characteristics of study participants.

All patients∞ ( )Normal C3c
( )
Elevated C3c
( )

Age (years)67 (12)68 (11)63 (13)
Female sex 42 (21)32 (20)10 (30)
Duration of follow-up for survivors [months]20 (6)20 (6)22 (4)
All-cause mortality23 (12)22 (14)1 (3)*
Diagnosis of heart failure known
 ≤5 years77 (39.1)63 (38.7)14 (42.4)
 5 years103 (52.3)87 (53.4)15 (30.7)
Predominant cause of heart failure
 Coronary artery disease92 (46.7)78 (48)13 (39.4)
 Dilated cardiomyopathy64 (32.5)50 (31)14 (42.4)
 Hypertension19 (9.6)17 (10)2 (6.1)
 Other22 (11.2)18 (11)4 (12.1)
NYHA functional class
 I/II144 (73.1)118 (72.4)25 (75.8)
 III/IV53 (26.9)45 (27.6)8 (24.2)
Left ventricular ejection fraction (%)44.2 (13.2)43.5 (13.2)48.0 (12.8)
Medical history
 Current smoker16 (8.1)14 (8.6)2 (6.1)
 Myocardial infarction81 (41.1)69 (42.3)11 (33.3)
Comorbidities
 Atrial fibrillation44 (22.3)39 (23.9)5 (15.2)
 Peripheral vascular disease 35 (17.8)28 (17.2)7 (21.2)
 Hypertension168 (85.3)138 (84.7)29 (87.9)
 Diabetes mellitus89 (45.2)68 (41.7)20 (60.6)*
 COPD31 (15.7)27 (16.6)4 (12.1)
 Anemia36 (18)29 (18)6 (18)
 Renal dysfunction96 (48.7)78 (47.9)17 (51.5)
 Uncured malignancy2 (1)2 (1.2)0
Devices
 ICD41 (20.8)32 (19.6)9 (27.3)
 CRT27 (13.7)18 (11.0)9 (27.3)*
Medication
 ACEi and/or ARB189 (96)156 (96)32 (97)
β-blocker182 (92)148 (91)33 (100)
 Aldosterone antagonist108 (55)87 (54)21 (64)
 Diuretic170 (86)139 (85)30 (91)
 Amiodarone19 (9.6)16 (9.8)3 (9.1)
 Digitalis72 (37)59 (36)13 (39)

Values are mean (SD) or (%). All patients imply results for all patients with the C3c measurement, including the only one with the diminished C3c value. * value < 0.05 in Mann-Whitney test, the comparison between the group with normal C3c and elevated C3c. °Heart rate according to electrocardiogram.
Comorbidities: atrial fibrillation: diagnosed from the electrocardiogram. Hypertension: sitting blood pressure > 140/90 mmHg or history of hypertension prior to the onset of heart failure or hypertensive heart disease accepted as predominant cause of heart failure. COPD: chronic obstructive pulmonary disease: history of this condition requiring bronchiolytic treatment or newly diagnosed according to the Global Initiative for Chronic Obstructive Lung Disease criteria [43]. Anemia according to WHO criteria: haemoglobin <12 g/dL in women and <13 g/dL in men [44]. Renal dysfunction: estimated glomerular filtration rate < 60 mL/min/1.73 m² [45]. ICD: implantable cardioverter-defibrillator. CRT: cardiac resynchronization therapy with a biventricular defibrillator; ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker.